These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1882 related items for PubMed ID: 12546119

  • 1. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 2. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [Abstract] [Full Text] [Related]

  • 3. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 4. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [Abstract] [Full Text] [Related]

  • 9. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M, Chaulet P, Darbyshire JH, Nunn A, Fox W.
    Rev Mal Respir; 1986 Jan; 3(2):73-85. PubMed ID: 3726263
    [Abstract] [Full Text] [Related]

  • 10. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML, Iuditskiĭ MV, Semenova OV.
    Probl Tuberk Bolezn Legk; 2004 Jan; (3):26-8. PubMed ID: 15338896
    [Abstract] [Full Text] [Related]

  • 11. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [Abstract] [Full Text] [Related]

  • 12. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS.
    Probl Tuberk Bolezn Legk; 2008 Feb; (12):60-3. PubMed ID: 19227326
    [Abstract] [Full Text] [Related]

  • 13. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 15. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP, Ebrahim S, Pillay V.
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 18. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep 11; 49(4):327-45. PubMed ID: 8000420
    [Abstract] [Full Text] [Related]

  • 19. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct 11; 78(4):330-6. PubMed ID: 6386028
    [Abstract] [Full Text] [Related]

  • 20. Tuberculosis treatment: dangerous regimens?
    Rieder HL, Arnadottir T, Trébucq A, Enarson DA.
    Int J Tuberc Lung Dis; 2001 Jan 11; 5(1):1-3. PubMed ID: 11263509
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 95.